🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this observer blind study is to assess the safety in terms o...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-22
Trial ID
NCT00547248
Treatments Being Tested
A study to investigate the incidence of influenza and influenza-related com...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-10-05
Trial ID
NCT00377611
Treatments Being Tested
The purpose of this trial is to evaluate the immunogenicity, the safety and...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-06-05
Trial ID
NCT02106390
Treatments Being Tested
The current study provides data necessary to evaluate the safety and immuno...
Status
Unknown
Location
Multiple Locations
Start Date
2022-01-25
Trial ID
NCT05140720
Treatments Being Tested
This will be a prospective observational study of lactating mothers who are...
Status
Completed
Location
Sinai Health System
Start Date
2021-01-17
Trial ID
NCT05004740
Treatments Being Tested
The purpose of this study is to evaluate the possibility that giving an inc...
Status
Completed
Location
Emory Children's Center - Pediatric Infectious Diseases
Start Date
2010-10
Trial ID
NCT01164553
Treatments Being Tested
This study will assess the durability of protection of a single immunisatio...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-03-01
Trial ID
NCT06293339
Treatments Being Tested
The objective of this study is to evaluate the safety, tolerability and imm...
Status
Unknown
Location
Al Kuwait Hospital (Al Baraha Hospital)
Start Date
2021-12-22
Trial ID
NCT05043311
The purpose of this study is to assess the safety, reactogenicity and immun...
Status
Withdrawn
Location
GSK Investigational Site
Start Date
2017-07-11
Trial ID
NCT03191383
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested